During the past decade, Bashkir State Medical University conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 9 clinical trials were completed, i.e. on average, 32.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 7 clinical trials were completed. i.e. 53.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bashkir State Medical University" #1 sponsor was "Janssen Research & Development, LLC" with 9 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Materia Medica Holding" with 3 trials sponsored, "AO GENERIUM" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bashkir State Medical University" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Chemical Diversity Research Institute" with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Bashkir State Medical University" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Carcinoma, Transitional Cell" (2 trials), "Idiopathic Thrombocytopenic Purpura" (2 trials), "Obesity" (2 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "Bashkir State Medical University" in a lesser frequency.

Most popular intervention types in "Bashkir State Medical University" are "Drug" (27 trials), "Biological" (5 trials), "Other" (5 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Amivantamab" (3 trials), "Carboplatin" (3 trials), "Pembrolizumab" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bashkir State Medical University" are 28 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Bashkir State Medical University". undefined are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Bashkir State Medical University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Bashkir State Medical University, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Bashkir State Medical University has several departments that took part in Clinical trials: "Bashkir State Medical University, Internal Medicine Department" - 5 trials